Concepedia

Bernhard Helk

BH

33

Publications

2.8K

Citations

26

H-Index

1985

Active since

Affiliations

Novartis (Switzerland)(Current)

Massachusetts Institute of Technology

BOKU University

VTT Technical Research Centre of Finland

Glykos (Finland)

Bernhard Helk is an author at Novartis (Switzerland) specializing in medicine, antibody engineering, and immunology.

Top concepts

Publications per year

1985–2024

33

Publications

33

Design of therapeutic proteins with enhanced stability

Naresh Chennamsetty, Vladimir Voynov, Veysel Kayser et al. · Proceedings of the National Academy of Sciences · 2009 · 586 citations · Full text

, , +15

Developability Index: A Rapid In Silico Tool for the Screening of Antibody Aggregation Propensity

Timothy M. Lauer, Neeraj J. Agrawal, Naresh Chennamsetty et al. · Journal of Pharmaceutical Sciences · 2011 · 211 citations

, , +15

Prediction of Aggregation Prone Regions of Therapeutic Proteins

Naresh Chennamsetty, Vladimir Voynov, Veysel Kayser et al. · The Journal of Physical Chemistry B · 2010 · 201 citations

Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies

Veysel Kayser, Naresh Chennamsetty, Vladimir Voynov et al. · Biotechnology Journal · 2010 · 163 citations

Aggregation-Prone Motifs in Human Immunoglobulin G

Naresh Chennamsetty, Bernhard Helk, Vladimir Voynov et al. · Journal of Molecular Biology · 2009 · 152 citations

, , +7

Rows per page

1–5 of 33